PRKAB2 emerges as a potential prognostic biomarker in pediatric adrenocortical tumor (2022)
- Authors:
- USP affiliated authors: VERONEZ, LUCIANA CHAIN - FMRP ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; ANTONINI, SONIR ROBERTO RAUBER - FMRP ; TONE, LUIZ GONZAGA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; MILAN, MIRELLA BARONI - ICB ; XAVIER, ALCIDES EUZEBIO TAVARES - FMRP ; NAGANO, LUÍS FERNANDO PEINADO - FMRP
- Unidades: FMRP; ICB
- DOI: 10.1002/pbc.29952
- Subjects: BIOMARCADORES; CARCINOMA; CÓRTEX ADRENAL; PROGNÓSTICO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pediatric Blood & Cancer
- Volume/Número/Paginação/Ano: v. 69, n. S5, p. S286-S287, res. EP300/#512, 2022
- Conference titles: Congress of the International Society of Paediatric Oncology (SIOP)
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
XAVIER, Alcides Euzebio Tavares et al. PRKAB2 emerges as a potential prognostic biomarker in pediatric adrenocortical tumor. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/pbc.29952. Acesso em: 26 jan. 2026. , 2022 -
APA
Xavier, A. E. T., Veronez, L. C., Nagano, L. F. P., Correa, C. A. P., Baroni, M., Santos, L., et al. (2022). PRKAB2 emerges as a potential prognostic biomarker in pediatric adrenocortical tumor. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/pbc.29952 -
NLM
Xavier AET, Veronez LC, Nagano LFP, Correa CAP, Baroni M, Santos L, Queiroz RG de P, Antonini SRR, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. PRKAB2 emerges as a potential prognostic biomarker in pediatric adrenocortical tumor [Internet]. Pediatric Blood & Cancer. 2022 ; 69( S5): S286-S287.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1002/pbc.29952 -
Vancouver
Xavier AET, Veronez LC, Nagano LFP, Correa CAP, Baroni M, Santos L, Queiroz RG de P, Antonini SRR, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. PRKAB2 emerges as a potential prognostic biomarker in pediatric adrenocortical tumor [Internet]. Pediatric Blood & Cancer. 2022 ; 69( S5): S286-S287.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1002/pbc.29952 - MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways
- MicroRNA-149-3p expression correlates with outcomes of adrenocortical tumor patients and affects proliferation and cell cycle progression of H295A adrenocortical cancer cell line
- Overexpression of MIR‐483‐3P and MIR‐149‐3P is associated with clinical characteristics of pediatric adrenocortical tumors
- Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- HDAC9 over-expression correlated with adverse prognosis in acute lymphoblastic leukemia
- A simplified PCR approach for minimal residual disease (MDR) detection at early treatment points stratifies children with acute lymphoblastic leukemia (ALL) into good and poor outcome groups
- mRNA expression of NMP2 and MMP9 and TIMP1 and TIMP2 in childhood all: potential role of TIMP1 as an adverse prognostic factor
Informações sobre o DOI: 10.1002/pbc.29952 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
